Pri-Med Clinical Focus - Targeting Type 2 Diabetes, London
Thursday 24 September 2009
Over 300 GPs, attended the launch of Pri-Med Clinical Focus: Targeting Type 2 Diabetes in London. The meeting was chaired by Professor Anthony Barnett, Consultant Physician and Clinical Director of Diabetes and Endocrinology, University of Birmingham and Heart of England NHS Foundation Trust, Birmingham. Delegates in attendance were treated to seven educational sessions, including:o “Diabetes: Have the risks diminished?” presented by Professor Anthony Barnett
o A insightful debate entitled “This House Believes that the NICE HbA1c Target of 6.5% is Attainable Without Additional Risk to Patient Health” delivered by Dr Marc Evans, Consultant Diabetologist, Llandough Hospital, Cardiff and Dr Martin Hadley - Brown, GP, Norfolk and PCDS Chairman. The Incretin Axis as a Target in the Management of Type 2 Diabetes presented by Professor Anthony Barnett
o Incretin Mimetics: Novel Treatments for Type 2 Diabetes presented by Professor Anthony Barnett
o Using GLP-1s in Practice presented by Gwen Hall, Diabetes Specialist Nurse in Primary Care and Clinical Educator, Haslemere
o Case Studies presented by Professor Anthony Barnett
o Panel and Audience Discussion presented by Professor Anthony Barnett, Dr Marc Evans and Gwen Hall
o Delegate Action Planning presented by Professor Anthony Barnett
Please see the Upcoming Meeting section on our website www.pri-medupdates.co.uk for further details on upcoming meetings in London